Tenaya Therapeutics, Inc. (TNYA)
0.7984
-0.01
(-1.20%)
USD |
NASDAQ |
May 21, 16:00
0.7968
0.00 (0.00%)
After-Hours: 19:59
Tenaya Therapeutics Profit Margin (Quarterly) : -8.57K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Krystal Biotech, Inc. | 48.07% |
| Vericel Corp. | -9.21% |
| Anavex Life Sciences Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.08% |
| Return on Assets | -63.32% |
| Return on Invested Capital | -70.45% |
| Gross Profit Margin (Quarterly) | -683.6% |
| Operating Margin (Quarterly) | -8.92K% |
| Return on Net Operating Assets | -180.0% |